See All Slides - tctmd.com

Slides

Presentation TCT 2012

Payment Reform: Prepare for the Changes

Presenter: Pamela Douglas

October 23, 2012

Presentation TCT 2012

TCT-64. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-hospital ST-segment Elevation: Findings from the Reperfusion of Acute...

Presenter: Akshay Bagai

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

DESyneBD (Elixir Medical) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

Yes: The Quantitative Threshold Should Be Lowered!

Presenter: Maurice Sarano

October 23, 2012

Presentation TCT 2012

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Presenter: Thomas McNamara

October 23, 2012

Presentation TCT 2012

Counterpulsation with SYMPHONY for Chronic Heart Failure

Presenter: Robert Dowling

October 23, 2012

Presentation TCT 2012

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Advertisement

Slides

Payment Reform: Prepare for the Changes

TCT-64. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-hospital ST-segment Elevation: Findings from the Reperfusion of Acute...

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

DESyneBD (Elixir Medical) Program Update

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Yes: The Quantitative Threshold Should Be Lowered!

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Counterpulsation with SYMPHONY for Chronic Heart Failure

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

HFPEF: Overview of Pathophysiology and Therapies

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content